Taking care of smoker cancer patients: A review and some recommendations

Annals of Oncology

Volumn 21, Issue 7, 2010, Pages 1404-1409

  Mazza, R ^a   Lina, M ^a   Boffi, R ^a   Invernizzi, G ^a   De Marco, C ^a   Pierotti, M ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Acute withdrawal nicotine symptoms; Empowerment; Hospitalized smoker cancer patient; Smoker care

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; ERLOTINIB; GEFITINIB; IRINOTECAN; NICOTINE;

BLOOD LEVEL; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURGERY; CLINICAL EFFECTIVENESS; DRUG POTENTIATION; DRUG SENSITIVITY; EMPOWERMENT; FATIGUE; HEALTH BEHAVIOR; HOSPITALIZATION; HUMAN; LIFESTYLE MODIFICATION; LUNG CANCER; MOUTH CANCER; MOUTH INFECTION; MUCOSA INFLAMMATION; NICOTINE REPLACEMENT THERAPY; PATIENT ATTITUDE; PATIENT CARE; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; RADIATION PNEUMONIA; REVIEW; RISK REDUCTION; SIDE EFFECT; SMOKING; SMOKING CESSATION; TASTE DISORDER; WEIGHT REDUCTION; WITHDRAWAL SYNDROME; XEROSTOMIA;

EID: 77954298739     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdp599     Document Type: Review

References (55)

1. Fiore MC, Jaén CR, Baker TB et al. Treating Tabacco Use and Dependance: 2008 Update. Clinical Practical Guideline. Rockville, MD: US Department of Health and Human Services. Public Health Service 2008.
2. Stead LF, Perera R, Bullen C et al. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev 2008;(1):CD000146.
3. Schnoll RA, Zhang B, Rue M et al. Brief physician-initiated quit-smoking strategies for clinical oncology setting: a trial coordinated by the eastern cooperative oncology group. J Clin Oncol 2003; 21: 355-365.
4. Gritz ER, Fingeret MC, Vidrine DJ et al. Successes and failure of the teachable moment. Cancer 2006; 106: 17-27.
5. Boffetta P, Tubiana M, Hill C et al. The causes of cancer in France. Ann Oncol 2009; 20: 550-555.
6. International Agency for Research on Cancer. Tobacco smoke and involuntary smoking. IARC Monographs on the Evaluation of Carcinogenic Risk to Humans. Lyon, France: IARC 2004; 83.
7. Associazione Italiana dei Registri Tumori (AIRTUM). Incidenza 1998-2002. http://www.registri-tumori.it/incidenza1998-2002/documenti/Numeri% 20assoluti%20-%20mortalit%E0.pdf (4 January 2010, date last accessed).
8. American Cancer Society. Cancer Facts and Figure 2007. Atlanta, GA: American Cancer Society 2007.
9. Samant RS, Tucker TL. Analysis of cigarette smoking habits of cancer patients referred to the Northeastern Ontario Regional Cancer Centre. J Cancer Educ 2003; 18: 157-160.
10. LoConte NK, Else-Quest NM, Eickhoff J et al. Assessment of guilt and shame in patients with non-small-cell lung cancer compared with patients with breast and prostate cancer. Clin Lung Cancer 2008; 9: 171-178.
11. Bowles EJA, Tuzzio L, Wiese CJ et al. Understanding high-quality cancer care. Cancer 2008; 112: 934-942.
12. Gritz ER, Vidrine DJ, Lazev AB. Smoking cessation in cancer patients. Never too late to quit. In Green CW, Given B, Champion VL, Kozachik S, Devoss DN (eds): Evidence-Based Cancer Care and Prevention: Behavioral Interventions. New York: Spring Publishing 2003; 107-140.
13. Bastian LA. Smoking cessation for hospital patient: an opportunity to increase the reach of effective smoking cessation programs. J Gen Intern Med 2008; 23: 1286-1287.
14. Sanderson Cox L, Africano NL, Tercyak KP, Taylor KL. Nicotine dependence treatment for patients with cancer. Cancer 2003; 98: 632-644.
15. Tucker MA, Murray N, Shaw EG et al. Second primary cancers related to smoking and treatment of small-cell lung cancer. Lung Cancer Working Cadre. J Natl Cancer Inst 1997; 89(23): 1782-1788.
16. Garces YI, Schroeder DR, Nirelli LM et al. The relationship between cigarette smoking and quality of life after lung cancer diagnosis. Chest 2004; 126: 1733-1741.
17. Garces YI, Schroeder DR, Nirelli LM et al. Second primary tumors following tobacco dependence treatments among head and neck cancer patients. Am J Clin Oncol 2007; 30(5): 531-539.
18. Duffy SA, Terrel JE, Valenstein M et al. Effects of smoking, alcohol and depression on the QoL of head and neck cancer patients. Gen Hosp Psychiatry 2002; 24: 140-147.
19. Parker A, Lohse C, Cheville J et al. Evaluation of the association of current cigarette smoking and outcome for patients with clear cell renal cell carcinoma. Int J Urol 2008; 15: 304-308.
20. Lorigan P, Radford J, Howell A, Thatcher N. Lung cancer after treatment for Hodgkin's lymphoma: a systematic review. Lancet Oncol 2005; 6: 773-779.
21. Salamini R, Polesel J, Spina M et al. The impact of tobacco smoking and alcohol drinking on survival of patients with non-HD lymphoma. Int J Cancer 2008; 122: 1624-1629.
22. Kaufinan EL et al. Effect of breast cancer radiotherapy and cigarette smoking on risk of second primary lung cancer. J Clin Oncol 2008; 26(3): 392-398.
23. Aksoy S, Harputluoglu H, Guler N et al. Influence of smoking history on breast cancer prognosis: retrospective study of 240 operable breast cancer patients who received adjuvant cyclophosphamide, doxorubicin and 5-fluorouracil chemotherapy regimen. Breast J 2007; 13(4): 431-432.
24. Kucera H, Enzelsberger H, Eppel W, Weghaupt K. The influence of nicotine abuse and diabetes mellitus on the results of primary irradiation in the treatment of carcinoma of the cervix. Cancer 1987; 60(1): 1-4.
25. Bako G, Dewar R, Hanson J, Hill G. Factors influencing the survival of patients with cancer of the prostate. CMAJ 1982; 127: 727-729.
26. Fleshner N, Garland J, Moadel A et al. Influence of smoking status on the disease-related outcomes of patients with tobacco associated superficial transitional cell carcinoma of the bladder. Cancer 1999; 86: 2337-2345.
27. Demark-Wahnefried W, Aziz N, Rowland J et al. Riding the crest of the teachable moment: promoting long-term health after the diagnosis of cancer. J Clin Oncol 2005; 23: 5814-5830.
28. Rigotti NA, Munafo MR, Stead LF. Interventions for smoking cessation in hospitalised patients. Cochrane Database Syst Rev 2007; 3: 1-28.
29. McBride CM, Emmons KM, Lipkus IM. Understanding the potential of teachable moments: the case of smoking cessation. Health Educ Res 2003; 18(2): 156-170.
30. Shimizu K, Nakata M, Hirami Y et al. Recent results regarding the clinical impact of smoking history on postoperative complications in lung cancer patients. Interact Cardiovasc Thorac Surg 2008; 7(6): 1001-1006.
31. Theadom A, Cropley M. Effects of preoperative smoking cessation on the incidence and risk of intraoperative and postoperative complications in adult smokers: a systematic review. Tob Control 2006; 15: 352-358.
32. Sorensen LT, Jørgensen T, Kirkeby LT et al. Smoking and alcohol abuse are major risk factors for anastomotic leakage in colorectal surgery. Br J Surg 1999; 86(7): 927-931.
33. Xu J, Huang H, Pan C et al. Nicotine inhibits apoptosis induced by cisplatin human oral cancer cells. Int J Oral Maxillofac Surg 2007; 36: 739-744.
34. Browman GP, Wog G, Hudson I. Influence of cigarette smoking on the efficacy of radiation therapy in head and neck cancer. N Engl J Med 1993; 328: 159-63.
35. Booi DI, Debats IB, Boeckx WD, van der Hulst RR. Risk factors and blood flow in the free transverse rectus abdominis (TRAM) flap: smoking and high flap weight impair the free TRAM flap microcirculation. Ann Plast Surg 2007; 59(4): 364-371.
36. Pao W, Miller V, Zakowski M et al. EGF receptor gene mutations are common in lung cancer from "never smokers" and are associated with sensitivity of tumor to gefitinib and erlotinib. Proc Natl Acad Sci U S A 2004; 101(36): 13306-13311.
37. Monson JM, Stark P, Reilly JJ et al. Clinical radiation pneumonitis and radiographic changes after thoracic radiation therapy for lung carcinoma. Cancer 1998; 82: 842-850.
38. Leithead JA, Ferguson JW, Hayes PC. Smoking-related morbidity and mortality following liver transplantation. Liver Transpl 2008; 14(8): 1159-1164.
39. McConathy K, Turner V, Johnston T et al. Analysis of smoking in patients referred for liver transplantation and its adverse impact of short-term outcomes. J Ky Med Assoc 2007; 105(6): 261-266.
40. Van der Bol JM, Mathijssen RHJ, Loos WJ et al. Cigarette smoking and Irinotecan treatment: pharmacokinetic interaction and effects on neutropenia. J Clin Oncol 2007; 25(19): 2719-2726.
41. Sardari Nia P, Weiler J, Colpaert C et al. Prognostic value of smoking status in operated NSLC. Lung Cancer 2005; 47: 351-359.
42. Tollerud DJ, Clark JW, Brown LM et al. Association of cigarette smoking with decreased numbers of circulating natural killer cells. Am Rev Respir Dis 1989; 139(1): 194-198.
43. Gritz ER, Dresler C, Sarna L. Smoking, the missing drug interaction in clinical trials: ignoring the obvious. Cancer Epidemiol Biomarkers Prev 2005; 14(10): 2287-2293.
44. McBride CM, Ostroff JS. Teachable moments for promoting smoking cessation: the context of cancer care and survivorship. Cancer Control 2003; 10(4): 325-333.
45. Solberg LI et al. Physician-patient interaction for smoking cessation medications: a dance of mutual accommodation? J Am Board Fam Med 2006; 19(3): 251-257.
46. Adamson G. Patient empowerment in cancer management healing the whole person. Compl Ther Nurs Midwifery 2003; 9(3): 109-113.
47. Møller A, Tønnesen H. Risk reduction: perioperative smoking intervention. Best Pract Res Clin Anaesthesiol 2006; 20(2): 237-248.
48. Hughes JR. Nicotine withdrawal symptoms. Effects of abstinence from tobacco: valid symptoms and time course. Nicotine Tob Res 2007; 9(3): 315-327.
49. Shiffman S. Effect of nicotine lozenges on affective smoking withdrawal symptoms: secondary analysis of randomized, double-blind, placebo-controlled clinical trial. Clin Ther 2008; 30(8): 1461-1475.
50. Klein LC, Corwin EJ, Ceballos RM. Leptin, hunger, and body weight: influence of gender, tobacco smoking, and smoking abstinence. Addict Behav 2004; 29(5): 921-927.
51. Froom P, Melamed S, Benbassat J. Smoking cessation and weight gain. J Fam Pract 1998; 46(6): 460-464.
52. Rìos-Bedoya CF, Snedecor SM, Pomerleau CS, Pomerleau OF. Association of withdrawal features with nicotine dependence as measured by Fagestrom Test for Nicotine Dependence (FTND). Addict Behav 2008; 33(8): 1086-1089.
53. Jiménez-Ruiz CA, Ulibarri MM, Besada NA et al. Progressive reduction using nicotine gum as a prelude to quitting. Nicotine Tob Res 2009; 11: 847-850.
54. Leone FT, Evers-Casey S, Veloski J et al. Short-, intermediate-, and long-term outcomes of Pennsylvania's continuum of tobacco education pilot project. Nicotine Tob Res 2009; 11(4): 387-393.
55. Chapman S. Going too far? Exploring the limits of smoking regulations. William Mitchell Law Rev 2008; 34(4): 1605-1620.